Sesen Bio, Inc.
SESNNASDAQHealthcare
$0.63
+$0.04(+7.29%)
Market Cap$127955770
P/E Ratio—
52W High$0.965
52W Low$0.365
Sesen Bio, Inc. (SESN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SESN · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Sep 30, 2023EPS Actual
-$53.13
Revenue
$0.00B
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Sep 30, 2023
After Market Close
✓ 2-Quarter EPS Beat Streak
SESN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2023 | Sep 30, 2023 | — | -$53.13 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2023 | May 8, 2023 | — | -$1.93 | — | $0.00B | — | — |
| ▲ Q1 FY2023 | Feb 28, 2023 | -$2.20 | -$0.80 | +63.6% | $0.04B | — | — |
| ▲ Q4 FY2022 | Nov 7, 2022 | -$3.10 | $2.00 | +164.5% | $0.04B | — | — |
| ▼ Q3 FY2022 | Aug 8, 2022 | -$2.60 | -$3.20 | -23.1% | — | — | — |
| ▲ Q2 FY2022 | May 9, 2022 | -$2.00 | -$0.08 | +96.0% | — | — | — |
| ▲ Q1 FY2022 | Feb 28, 2022 | -$1.47 | $0.80 | +154.4% | $0.03B | $0.05B | -42.6% |
Q3 FY2023
Sep 30, 2023
EPS Actual
-$53.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
May 8, 2023
EPS Actual
-$1.93
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Feb 28, 2023Beat
EPS Actual
-$0.80
EPS Est.
-$2.20
EPS Surpr.
+63.6%
Revenue
$0.04B
Q4 FY2022
Nov 7, 2022Beat
EPS Actual
$2.00
EPS Est.
-$3.10
EPS Surpr.
+164.5%
Revenue
$0.04B
Q3 FY2022
Aug 8, 2022Miss
EPS Actual
-$3.20
EPS Est.
-$2.60
EPS Surpr.
-23.1%
Revenue
—
Q2 FY2022
May 9, 2022Beat
EPS Actual
-$0.08
EPS Est.
-$2.00
EPS Surpr.
+96.0%
Revenue
—
Q1 FY2022
Feb 28, 2022Beat
EPS Actual
$0.80
EPS Est.
-$1.47
EPS Surpr.
+154.4%
Revenue
$0.03B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2021 | $-0.21 | $-0.17 | $-0.14 | 13 |
| Q1 FY2015 | $-0.70 | $-0.58 | $-0.46 | 11 |
| Q1 FY2014 | $-0.45 | $-0.38 | $-0.30 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2021 | $0.0B | $0.0B | $0.0B | 13 |
| Q1 FY2015 | $0.0B | $0.0B | $0.0B | 11 |
| Q1 FY2014 | $0.0B | $0.0B | $0.0B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2023 | Sep 30, 2023 | — | $0.63 | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.63 | — | — |
| — Q2 FY2023 | May 8, 2023 | — | $0.63 | — | — |
| ▲ Q1 FY2023 | Feb 28, 2023 | +63.6% | $0.58 | $0.58 | -0.60% |
| ▲ Q4 FY2022 | Nov 7, 2022 | +164.5% | $0.54 | $0.55 | +0.55% |
| ▼ Q3 FY2022 | Aug 8, 2022 | -23.1% | $0.73 | $0.73 | -0.18% |
| ▲ Q2 FY2022 | May 9, 2022 | +96.0% | $0.54 | $0.47 | -13.35% |
| ▲ Q1 FY2022 | Feb 28, 2022 | +154.4% | $0.63 | $0.63 | +0.92% |
Q3 FY2023—
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$0.63
Price After
—
Q2 FY2023—
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.63
Price After
—
Q2 FY2023—
Report Date
May 8, 2023
EPS Beat/Miss
—
Price Before
$0.63
Price After
—
Q1 FY2023-0.60%
Report Date
Feb 28, 2023
EPS Beat/Miss
+63.6%
Price Before
$0.58
Price After
$0.58
Q4 FY2022+0.55%
Report Date
Nov 7, 2022
EPS Beat/Miss
+164.5%
Price Before
$0.54
Price After
$0.55
Q3 FY2022-0.18%
Report Date
Aug 8, 2022
EPS Beat/Miss
-23.1%
Price Before
$0.73
Price After
$0.73
Q2 FY2022-13.35%
Report Date
May 9, 2022
EPS Beat/Miss
+96.0%
Price Before
$0.54
Price After
$0.47
Q1 FY2022+0.92%
Report Date
Feb 28, 2022
EPS Beat/Miss
+154.4%
Price Before
$0.63
Price After
$0.63
Avg Beat Reaction-3.12%
Avg Miss Reaction-0.18%
Beat Rate4 / 8 quarters
Largest Move-13.35% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SESN ends December
Sesen Bio, Inc. (SESN) most recently reported earnings on September 30, 2023 for Q3 FY2023, posting EPS of $-53.13 (in line with the analyst consensus of —). SESN has beaten EPS estimates for 2 consecutive quarters. The next SESN earnings date is expected around September 1, 2026.
Each quarter, investors track SESN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SESN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SESN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SESN earnings · 4 questionsSesen Bio, Inc.'s next earnings report is expected around September 1, 2026. SESN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SESN historically reports after market close (AMC).
SESN earnings datewhen is SESN earningsSESN next earnings datewhen does SESN report earningsSESN earnings calendar
▸ Source: FMP · Sesen Bio, Inc. SEC filings · US GAAP · Sesen Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026